Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE

Genus

  • Genus: Animal genetics firm begins recovery after gruelling year

    Food

    Animal genetics specialist Genus has shown early signs of stabilising after a gruelling year during which its share price tumbled by 20 per cent. Shares in the London-listed firm nose-dived in 18 per cent in a week in February after it reported collapses in the pork price and its bovine volumes in China, one of [...]

    Pigs in a barn. Last year Genus created gene editing technology that makes pigs immune from swine flu
  • Genus trading in line with downgraded forecasts as China turbulence continues

    pharma

    Animal genetics company Genus said it expects its full year results to be in line with expectations, after it downgraded its forecasts in February.

    London-listed Genus said in a trading update that its pre-tax profit was set to sit somewhere between £58m and £61
  • Shares crash for animal genetics firm Genus after China turbulence

    Genus

    Its other business, ABS Dairy, it said was operating in a "challenging market" and saw volumes decrease six per cent, while demand for "dairy genetics" in China was hit hard by a "double-digit decline in the dairy heard".

    Life On A Dairy Farm The Closed Herd
  • Ailing medical equipment maker Convatec hopes new boss will transform fortunes

    March 25, 2019

    Convatec’s shares rose this morning as it announced it had poached Karim Bitar, chief executive of Genus, as its new boss. The struggling medical equipment manufacturer confirmed the appointment this morning, meaning it will finally have a permanent chief after previous CEO Paul Moraviec stepped down last October. Read more: Shares in Convatec fall 20 [...]

  • Animal genetics firm Genus to buy stake in Brazilian specialist In Vitro Brasil

    February 16, 2015

    Bull and pig sperm specialist Genus has signed an agreement to buy 51 per cent of In Vitro Brasil (IVB) through its bovine genetics business ABS. The Basingstoke-headquartered company, which had global revenues of more than £4m last year, will pay 20m Brazilian Real (£4.6m) for the deal. It plans to acquire the remaining 49 [...]

Trending Articles

  • Harry Styles at Wembley Stadium review: running through the grief

  • Nottingham Forest owner Marinakis announces £210m stadium plans

  • Burnham told to launch £100bn tax reform package

  • I’ve taken the best train trips in the world. Here are my 5 favourites

  • Natwest boss becomes latest City figure caught in AI social media scam

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy